Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Moynihan

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
BMJ (Clinical Research Ed.)|November 2, 2012
Too much medicine, not enough mirthRay Moynihan
BMJ (Clinical Research Ed.)|March 20, 2015
Preventing overdiagnosis: the myth, the music, and the medical meetingRay Moynihan
BMJ (Clinical Research Ed.)|August 26, 2010
Who benefits from treating prehypertension?Ray Moynihan
BMJ (Clinical Research Ed.)|January 29, 2005
New free trade agreement sparks fight over drug pricingRay Moynihan
BMJ (Clinical Research Ed.)|January 22, 2005
US drug industry's claims of other countries "freeloading" are a mythRay Moynihan
BMJ (Clinical Research Ed.)|October 25, 2003
Safety concerns about breast implants persistRay Moynihan
BMJ (Clinical Research Ed.)|February 7, 2004
FDA advisory panel calls for suicide warnings over new antidepressantsRay Moynihan
BMJ (Clinical Research Ed.)|June 21, 2013
Australia moves closer to full disclosure of drug company payments to doctorsRay Moynihan
BMJ (Clinical Research Ed.)|September 14, 2002
Alosetron: a case study in regulatory capture, or a victory for patients' rights?Ray Moynihan
BMJ (Clinical Research Ed.)|September 28, 2002
FDA fails to reduce accessibility of paracetamol despite 450 deaths a yearRay Moynihan
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|November 2, 2012
Too much medicine, not enough mirthRay Moynihan
BMJ (Clinical Research Ed.)|March 20, 2015
Preventing overdiagnosis: the myth, the music, and the medical meetingRay Moynihan
BMJ (Clinical Research Ed.)|August 26, 2010
Who benefits from treating prehypertension?Ray Moynihan
BMJ (Clinical Research Ed.)|January 29, 2005
New free trade agreement sparks fight over drug pricingRay Moynihan
BMJ (Clinical Research Ed.)|January 22, 2005
US drug industry's claims of other countries "freeloading" are a mythRay Moynihan
BMJ (Clinical Research Ed.)|October 25, 2003
Safety concerns about breast implants persistRay Moynihan
BMJ (Clinical Research Ed.)|February 7, 2004
FDA advisory panel calls for suicide warnings over new antidepressantsRay Moynihan
BMJ (Clinical Research Ed.)|June 21, 2013
Australia moves closer to full disclosure of drug company payments to doctorsRay Moynihan
BMJ (Clinical Research Ed.)|September 14, 2002
Alosetron: a case study in regulatory capture, or a victory for patients' rights?Ray Moynihan
BMJ (Clinical Research Ed.)|September 28, 2002
FDA fails to reduce accessibility of paracetamol despite 450 deaths a yearRay Moynihan
Pageof 17